Affirm Holdings, Inc. Weighted Average Exercise Price of Exercisable Options increased by 0.3% to $19.51 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.8%, from $18.79 to $19.51.
An increase may suggest higher historical grant prices, while a decrease relative to market price indicates higher potential dilution risk.
This metric represents the weighted average price at which holders of vested share-based payment options can purchase co...
Standard disclosure for large-cap industrial firms with significant equity compensation programs.
weighted_avg_exercise_price_exercisable| Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.70 | $10.70 | $12.92 | $15.11 | $14.87 | $14.66 | $14.11 | $15.26 | $15.49 | $16.85 | $18.16 | $18.79 | $19.31 | $19.46 | $19.51 |
| QoQ Change | — | +0.0% | +20.7% | +17.0% | -1.6% | -1.4% | -3.8% | +8.2% | +1.5% | +8.8% | +7.8% | +3.5% | +2.8% | +0.8% | +0.3% |
| YoY Change | — | — | — | +41.2% | +39.0% | +13.5% | -6.6% | +2.6% | +5.7% | +19.4% | +19.0% | +21.3% | +14.6% | +7.2% | +3.8% |